論文
Maki Hirao, Kohei Yamazaki, Kentaro Watanabe, Kiyoshi Mukai, Shigemichi Hirose, MakotoOsada, Yuiko Tsukada, Hisako Kunieda, Ryunosuke Denda, Takahide Kikuchi, Hiroki
Sugimori, Shinichiro Okamoto, Yutaka (2022 Feb). Negative E-cadherin expression onbone marrow myeloma cell membranes is associated with extramedullary disease.
F1000Research 11, 245.
Kunieda Hisako, Ryunosuke Denda, Kohei Yamazaki, Maki Hirao, Yuiko Tsukada, Yu
Iwabuchi, Eisuke Shiomi, Shigeru Watanabe, Shinichiro Okamoto, Takahide Kikuchi (2022Feb). Philadelphia chromosome-positive acute lymphoblastic leukemia incidentallydetected
byfluorodeoxyglucose-positronemission
tomography/computed
tomography at a health checkup. Internal Medicine, Article ID 8900-21. Advance online
publication.
Yutaka Hattori, Takumi Futo, Ryo Uozaki, Daiju Ichikawa, Takashi Yamaguchi, Tomofumi
Yamamoto, Maiko Matsushita, Maki Hirao (2022 Feb). Integrin β5 and β7 expression inlenalidomide-resistant multiple myeloma cells. International Journal of Hematology 115,605-608.
Ryo Ogawa, Maki Hirao, Taro Umezu, Shigeru Yanagimoto (2022 Feb). Total hip
arthroplasty with a cementless acetabular component and impaction bone grafting fordysplastic osteoarthritis complicated by multiple myeloma. Case Reports inOrthopedics, article ID 3939356, 5 pages.
Masataro Toda, Kentaro Fujii, Ayumi Yoshifuji, Yasushi Kondo, Kazuto Itoh, Kazuhiko Sekine,Takahide Kikuchi, Munekazu Ryuzaki. (2022 Jan) Clinical efficacy and safety ofcombination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in
HD patients. Clin Exp Nephrol. 26(1):75-85.
COVID-19 Host Genetics Initiative (Takahide Kikuchi) (2021 Dec). Mapping the humangenetic architecture of COVID-19. Nature 600(7889):472-477.
Satoru Kuriyama, Kei Matsumoto, Maki Hirao, Otoya Miho (2021 Nov). SGLT2 阻害薬はな
ぜ非糖尿病患者においても心・腎保護的か？ [Why do SGLT2 Inhibitors Act as CardioRenal Protective even in Non-diabetics?] Rinsho yakuri/Japanese Journal of ClinicalPharmacology and Therapeutics 52(6): 157-164.
Makoto Osada, Keiko Maruyama, Koichi Kokame, Ryunosuke Denda, Kohei Yamazaki,Hisako Kunieda, Maki Hirao, Seiji Madoiwa, Nobuo Okumura, Mitsuru Murata, Yasuo Ikeda,Yuiko Tsukada, Takahide Kikuchi (2021 Oct). A novel homozygous variant of thethrombomodulin gene causes a hereditary bleeding disorder. Blood Advances
5(19):3830-3838.
Toshinori Sasaki, Tomohide Adachi, Kazuto Itoh, Mayumi Kubota, Takuya Yamagishi, Maki
Hirao, Haruhiko Isawa, Kazunori Oishi, Keigo Shibayama, Kyoko Sawabe (2021 Sep).
Detection of Bartonella quintana infection among the Homeless Population in Tokyo,

Japan, from 2013–2015. Japanese Journal of Infectious Diseases 74(5):411-415.
藤井健太郎, 中村守男, 丸木孟知, 土屋悠海, 伊藤航人, 谷山大輔, 関根和彦, 石井 誠, 福永興壱, 菊池隆秀（2021 May）．当院で入院加療した新型コロナウイルス感染症患者の臨
床像 第 1 波と第 2 波の比較．日本呼吸器学会誌 10(3):236-244.
研究発表
長田 眞，丸山慶子，小亀浩市，窓岩清治，山崎皓平，國枝尚子，平尾磨樹，村田 満，池田康夫，塚田唯子，菊池隆秀（2022 Feb）．出血傾向をきたし，新規に同定された先天性トロンボモジュリン異常症と凝固線溶病態. 第 16 回日本血栓止血学会 学術標準化委員会
シンポジウム，血栓溶解部会「線溶 REVISIT：古くて新しい話題」
伊崎慶史郎，平尾磨樹，傳田竜之介，山崎皓平，國枝尚子，塚田唯子，遠藤彩佳，菊池隆秀（2021 Dec）．ホジキンリンパ腫発症 22 年後に心サルコイドーシスと診断された 1 症
例．第 674 回日本内科学会関東地方会， 東京「血液」p.52.
平尾磨樹，傳田竜之介，山崎皓平，國枝尚子，塚田唯子，杉森裕樹，菊池隆秀（2021 Sep）．
造血幹細胞移植を施行した患者の体力と予後：後ろ向きコホート研究 [Physical Fitnessand Prognosis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A
Retrospective Cohort Study]．第 76 回日本体力医学会大会，三重．「スポーツと疾患－その他の疾患」 Sports medicine and diseases/ Rehabilitation and exercise therapy. The
Journal of Physical Fitness and Sports Medicine, 10(6), 398-403.
國枝尚子，傳田竜之介，山崎皓平，平尾磨樹，塚田唯子，菊池隆秀（2021 Sep）．FDG-PET/CTにより早期に急性リンパ性白血病を診断できた一例．第 83 回日本血液学会学術集会，京都Page PS-18-7.
相馬友美, 藤井健太郎, 丸木孟知, 伊藤航人, 吉藤 歩, 谷山大輔, 中村守男, 菊池隆秀
（2021 Apr）．軽症 COVID-19 患者に対するナファモスタット単剤投与の有用性．感染症
学雑誌 95（臨増）：319.